[Use of 131I-meta-iodobenzylguanidine in pediatric oncology]
- PMID: 4000978
[Use of 131I-meta-iodobenzylguanidine in pediatric oncology]
Abstract
The detection of specific trapping of MIBG by neuroblastoma cells is of great importance for the diagnosis and management of neuroblastoma in childhood. The specificity and sensitivity of the test has been demonstrated by Kimmig and Feine in a multi-center study. Moreover, MIBG might be used in the therapy of neuroblastoma. The first therapeutic cases allow slight optimism. There remain however still a number of questions to be answered. In vitro investigations of uptake kinetics and cytotoxicity of MIBG performed by our group provided valuable information for clinical investigations.
Similar articles
-
Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.Prog Clin Biol Res. 1991;366:439-45. Prog Clin Biol Res. 1991. PMID: 2068157 No abstract available.
-
Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.J Nucl Med. 1992 Oct;33(10):1735-40. J Nucl Med. 1992. PMID: 1403138
-
Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.Radiology. 1992 Aug;184(2):463-7. doi: 10.1148/radiology.184.2.1620849. Radiology. 1992. PMID: 1620849
-
Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).Int J Rad Appl Instrum B. 1987;14(3):183-9. doi: 10.1016/0883-2897(87)90041-9. Int J Rad Appl Instrum B. 1987. PMID: 3312118 Review.
-
Nuclear medicine imaging in pediatric oncology.J Nucl Biol Med (1991). 1994 Mar;38(1):76-84. J Nucl Biol Med (1991). 1994. PMID: 8075180 Review.
MeSH terms
Substances
LinkOut - more resources
Medical